Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3766055017 | Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3766056016 | Amorolfine hydrochloride 50 mg/mL cutaneous solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has concentration strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | mg | false | Inferred relationship | Some | 1 | |
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has manufactured dose form | Cutaneous solution | false | Inferred relationship | Some | ||
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Amorolfine hydrochloride | false | Inferred relationship | Some | 1 | |
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Amorolfine hydrochloride | false | Inferred relationship | Some | 1 | |
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Is a | Amorolfine only product in cutaneous dose form | false | Inferred relationship | Some | ||
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | mL | false | Inferred relationship | Some | 1 | |
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | Plays role | Antifungal therapeutic role (role) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)